These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 32483117)

  • 1. Suppression of unwanted CRISPR-Cas9 editing by co-administration of catalytically inactivating truncated guide RNAs.
    Rose JC; Popp NA; Richardson CD; Stephany JJ; Mathieu J; Wei CT; Corn JE; Maly DJ; Fowler DM
    Nat Commun; 2020 Jun; 11(1):2697. PubMed ID: 32483117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CRISPR GUARD protects off-target sites from Cas9 nuclease activity using short guide RNAs.
    Coelho MA; De Braekeleer E; Firth M; Bista M; Lukasiak S; Cuomo ME; Taylor BJM
    Nat Commun; 2020 Aug; 11(1):4132. PubMed ID: 32807781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome Editing with CRISPR-Cas9: Can It Get Any Better?
    Haeussler M; Concordet JP
    J Genet Genomics; 2016 May; 43(5):239-50. PubMed ID: 27210042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimizing sgRNA length to improve target specificity and efficiency for the GGTA1 gene using the CRISPR/Cas9 gene editing system.
    Matson AW; Hosny N; Swanson ZA; Hering BJ; Burlak C
    PLoS One; 2019; 14(12):e0226107. PubMed ID: 31821359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimization of genome editing through CRISPR-Cas9 engineering.
    Zhang JH; Adikaram P; Pandey M; Genis A; Simonds WF
    Bioengineered; 2016 Apr; 7(3):166-74. PubMed ID: 27340770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [CRISPR/CAS9, the King of Genome Editing Tools].
    Bannikov AV; Lavrov AV
    Mol Biol (Mosk); 2017; 51(4):582-594. PubMed ID: 28900076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted genome editing in human cells using CRISPR/Cas nucleases and truncated guide RNAs.
    Fu Y; Reyon D; Joung JK
    Methods Enzymol; 2014; 546():21-45. PubMed ID: 25398334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Boosting activity of high-fidelity CRISPR/Cas9 variants using a tRNA
    He X; Wang Y; Yang F; Wang B; Xie H; Gu L; Zhao T; Liu X; Zhang D; Ren Q; Liu X; Liu Y; Gao C; Gu F
    J Biol Chem; 2019 Jun; 294(23):9308-9315. PubMed ID: 31010827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-viral and viral delivery systems for CRISPR-Cas9 technology in the biomedical field.
    He ZY; Men K; Qin Z; Yang Y; Xu T; Wei YQ
    Sci China Life Sci; 2017 May; 60(5):458-467. PubMed ID: 28527117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Target binding and residence: a new determinant of DNA double-strand break repair pathway choice in CRISPR/Cas9 genome editing.
    Feng Y; Liu S; Chen R; Xie A
    J Zhejiang Univ Sci B; 2021 Jan; 22(1):73-86. PubMed ID: 33448189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Design of Guide RNA for CRISPR/Cas Plant Genome Editing].
    Gerashchenkov GA; Rozhnova NA; Kuluev BR; Kiryanova OY; Gumerova GR; Knyazev AV; Vershinina ZR; Mikhailova EV; Chemeris DA; Matniyazov RT; Baimiev AK; Gubaidullin IM; Baimiev AK; Chemeris AV
    Mol Biol (Mosk); 2020; 54(1):29-50. PubMed ID: 32163387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mismatch Intolerance of 5'-Truncated sgRNAs in CRISPR/Cas9 Enables Efficient Microbial Single-Base Genome Editing.
    Lee HJ; Kim HJ; Lee SJ
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34208669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-Penetrating Peptide-Mediated Delivery of Cas9 Protein and Guide RNA for Genome Editing.
    Suresh B; Ramakrishna S; Kim H
    Methods Mol Biol; 2017; 1507():81-94. PubMed ID: 27832534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single nucleotide substitutions effectively block Cas9 and allow for scarless genome editing in Caenorhabditis elegans.
    Medley JC; Hebbar S; Sydzyik JT; Zinovyeva AY
    Genetics; 2022 Jan; 220(1):. PubMed ID: 34791245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Highly specific and efficient CRISPR/Cas9-catalyzed homology-directed repair in Drosophila.
    Gratz SJ; Ukken FP; Rubinstein CD; Thiede G; Donohue LK; Cummings AM; O'Connor-Giles KM
    Genetics; 2014 Apr; 196(4):961-71. PubMed ID: 24478335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Doxycycline-Dependent Self-Inactivation of CRISPR-Cas9 to Temporally Regulate On- and Off-Target Editing.
    Kelkar A; Zhu Y; Groth T; Stolfa G; Stablewski AB; Singhi N; Nemeth M; Neelamegham S
    Mol Ther; 2020 Jan; 28(1):29-41. PubMed ID: 31601489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amplification-free long-read sequencing reveals unforeseen CRISPR-Cas9 off-target activity.
    Höijer I; Johansson J; Gudmundsson S; Chin CS; Bunikis I; Häggqvist S; Emmanouilidou A; Wilbe M; den Hoed M; Bondeson ML; Feuk L; Gyllensten U; Ameur A
    Genome Biol; 2020 Dec; 21(1):290. PubMed ID: 33261648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential pitfalls of CRISPR/Cas9-mediated genome editing.
    Peng R; Lin G; Li J
    FEBS J; 2016 Apr; 283(7):1218-31. PubMed ID: 26535798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential high-frequency off-target mutagenesis induced by CRISPR/Cas9 in Arabidopsis and its prevention.
    Zhang Q; Xing HL; Wang ZP; Zhang HY; Yang F; Wang XC; Chen QJ
    Plant Mol Biol; 2018 Mar; 96(4-5):445-456. PubMed ID: 29476306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simplified CRISPR-Mediated DNA Editing in Multicellular Eukaryotes.
    Kumar R; Tiwari K; Saudagar P
    Methods Mol Biol; 2023; 2575():241-260. PubMed ID: 36301478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.